Cargando…
A Galantamine–Curcumin Hybrid Decreases the Cytotoxicity of Amyloid-Beta Peptide on SH-SY5Y Cells
Misfolded amyloid beta (Aβ) peptides aggregate and form neurotoxic oligomers. Membrane and mitochondrial damages, calcium dysregulation, oxidative stress, and fibril deposits are among the possible mechanisms of Aβ cytotoxicity. Galantamine (GAL) prevents apoptosis induced by Aβ mainly through the a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307467/ https://www.ncbi.nlm.nih.gov/pubmed/34299209 http://dx.doi.org/10.3390/ijms22147592 |
_version_ | 1783728056768135168 |
---|---|
author | Mladenova, Kirilka Stavrakov, Georgi Philipova, Irena Atanasova, Mariyana Petrova, Svetla Doumanov, Jordan Doytchinova, Irini |
author_facet | Mladenova, Kirilka Stavrakov, Georgi Philipova, Irena Atanasova, Mariyana Petrova, Svetla Doumanov, Jordan Doytchinova, Irini |
author_sort | Mladenova, Kirilka |
collection | PubMed |
description | Misfolded amyloid beta (Aβ) peptides aggregate and form neurotoxic oligomers. Membrane and mitochondrial damages, calcium dysregulation, oxidative stress, and fibril deposits are among the possible mechanisms of Aβ cytotoxicity. Galantamine (GAL) prevents apoptosis induced by Aβ mainly through the ability to stimulate allosterically the α7 nAChRs and to regulate the calcium cytosolic concentration. Here, we examined the cytoprotective effects of two GAL derivatives, namely compounds 4b and 8, against Aβ cytotoxicity on the human neuroblastoma cell line SH-SY5Y. The protective effects were tested at simultaneous administration, pre-incubation and post-incubation, with Aβ. GAL and curcumin (CU) were used in the study as reference compounds. It was found that 4b protects cells in a similar mode as GAL, while compound 8 and CU potentiate the toxic effects of Aβ. Allosteric stimulation of α7 nAChRs is suggested as a possible mechanism of the cytoprotectivity of 4b. These and previous findings characterize 4b as a prospective non-toxic multi-target agent against neurodegenerative disorders with inhibitory activity on acetylcholinesterase, antioxidant, and cytoprotective properties. |
format | Online Article Text |
id | pubmed-8307467 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83074672021-07-25 A Galantamine–Curcumin Hybrid Decreases the Cytotoxicity of Amyloid-Beta Peptide on SH-SY5Y Cells Mladenova, Kirilka Stavrakov, Georgi Philipova, Irena Atanasova, Mariyana Petrova, Svetla Doumanov, Jordan Doytchinova, Irini Int J Mol Sci Article Misfolded amyloid beta (Aβ) peptides aggregate and form neurotoxic oligomers. Membrane and mitochondrial damages, calcium dysregulation, oxidative stress, and fibril deposits are among the possible mechanisms of Aβ cytotoxicity. Galantamine (GAL) prevents apoptosis induced by Aβ mainly through the ability to stimulate allosterically the α7 nAChRs and to regulate the calcium cytosolic concentration. Here, we examined the cytoprotective effects of two GAL derivatives, namely compounds 4b and 8, against Aβ cytotoxicity on the human neuroblastoma cell line SH-SY5Y. The protective effects were tested at simultaneous administration, pre-incubation and post-incubation, with Aβ. GAL and curcumin (CU) were used in the study as reference compounds. It was found that 4b protects cells in a similar mode as GAL, while compound 8 and CU potentiate the toxic effects of Aβ. Allosteric stimulation of α7 nAChRs is suggested as a possible mechanism of the cytoprotectivity of 4b. These and previous findings characterize 4b as a prospective non-toxic multi-target agent against neurodegenerative disorders with inhibitory activity on acetylcholinesterase, antioxidant, and cytoprotective properties. MDPI 2021-07-15 /pmc/articles/PMC8307467/ /pubmed/34299209 http://dx.doi.org/10.3390/ijms22147592 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mladenova, Kirilka Stavrakov, Georgi Philipova, Irena Atanasova, Mariyana Petrova, Svetla Doumanov, Jordan Doytchinova, Irini A Galantamine–Curcumin Hybrid Decreases the Cytotoxicity of Amyloid-Beta Peptide on SH-SY5Y Cells |
title | A Galantamine–Curcumin Hybrid Decreases the Cytotoxicity of Amyloid-Beta Peptide on SH-SY5Y Cells |
title_full | A Galantamine–Curcumin Hybrid Decreases the Cytotoxicity of Amyloid-Beta Peptide on SH-SY5Y Cells |
title_fullStr | A Galantamine–Curcumin Hybrid Decreases the Cytotoxicity of Amyloid-Beta Peptide on SH-SY5Y Cells |
title_full_unstemmed | A Galantamine–Curcumin Hybrid Decreases the Cytotoxicity of Amyloid-Beta Peptide on SH-SY5Y Cells |
title_short | A Galantamine–Curcumin Hybrid Decreases the Cytotoxicity of Amyloid-Beta Peptide on SH-SY5Y Cells |
title_sort | galantamine–curcumin hybrid decreases the cytotoxicity of amyloid-beta peptide on sh-sy5y cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307467/ https://www.ncbi.nlm.nih.gov/pubmed/34299209 http://dx.doi.org/10.3390/ijms22147592 |
work_keys_str_mv | AT mladenovakirilka agalantaminecurcuminhybriddecreasesthecytotoxicityofamyloidbetapeptideonshsy5ycells AT stavrakovgeorgi agalantaminecurcuminhybriddecreasesthecytotoxicityofamyloidbetapeptideonshsy5ycells AT philipovairena agalantaminecurcuminhybriddecreasesthecytotoxicityofamyloidbetapeptideonshsy5ycells AT atanasovamariyana agalantaminecurcuminhybriddecreasesthecytotoxicityofamyloidbetapeptideonshsy5ycells AT petrovasvetla agalantaminecurcuminhybriddecreasesthecytotoxicityofamyloidbetapeptideonshsy5ycells AT doumanovjordan agalantaminecurcuminhybriddecreasesthecytotoxicityofamyloidbetapeptideonshsy5ycells AT doytchinovairini agalantaminecurcuminhybriddecreasesthecytotoxicityofamyloidbetapeptideonshsy5ycells AT mladenovakirilka galantaminecurcuminhybriddecreasesthecytotoxicityofamyloidbetapeptideonshsy5ycells AT stavrakovgeorgi galantaminecurcuminhybriddecreasesthecytotoxicityofamyloidbetapeptideonshsy5ycells AT philipovairena galantaminecurcuminhybriddecreasesthecytotoxicityofamyloidbetapeptideonshsy5ycells AT atanasovamariyana galantaminecurcuminhybriddecreasesthecytotoxicityofamyloidbetapeptideonshsy5ycells AT petrovasvetla galantaminecurcuminhybriddecreasesthecytotoxicityofamyloidbetapeptideonshsy5ycells AT doumanovjordan galantaminecurcuminhybriddecreasesthecytotoxicityofamyloidbetapeptideonshsy5ycells AT doytchinovairini galantaminecurcuminhybriddecreasesthecytotoxicityofamyloidbetapeptideonshsy5ycells |